Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients

BACKGROUND: Adjuvant therapy for T3N0 rectal cancer was controversial with respect to both radiation and the use of a combined regimen of chemotherapy. We evaluated both clinical features and biomarkers and sought to determine risk factors for those patients retrospectively. METHODS: A total of 122...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhu, Ji, Xu, Ye, Gu, Weilie, Peng, Junjie, Cai, Gang, Cai, Guoxiang, Sun, Wenjie, Shen, Weiqi, Cai, Sanjun, Zhang, Zhen
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3009675/
https://ncbi.nlm.nih.gov/pubmed/21156077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-5-118
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars